4.4 Article

Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Otorhinolaryngology

Characteristics and Outcomes in Head and Neck Sarcomatoid Squamous Cell Carcinoma: The Cleveland Clinic Experience

Katie M. Mingo et al.

Summary: Sarcomatoid squamous cell carcinoma of the head and neck is a rare and aggressive disease variant with high recurrence rates and high mortality. High risk features such as lymphovascular space invasion may indicate the need for more aggressive therapy.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2021)

Article Oncology

HDAC inhibitors suppress the proliferation, migration and invasiveness of human head and neck squamous cell carcinoma cells via p63-mediated tight junction molecules and p21-mediated growth arrest

Akito Kakiuchi et al.

Summary: HDAC inhibitors suppress proliferation, migration, and invasiveness of HNSCC by downregulating p63-mediated tight junction molecules JAM-A and claudin-1, and inducing growth arrest mediated by p63 or p21.

ONCOLOGY REPORTS (2021)

Article Multidisciplinary Sciences

Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis

Karim Mrouj et al.

Summary: Ki-67, while not necessary for cell proliferation, plays a crucial role in tumor initiation, growth, and metastasis. Its absence leads to changes in the transcriptome and immune response, making cancer cells more susceptible to drugs and immune attacks.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Oncology

The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma

Yali Cheng et al.

Summary: Oral squamous cell carcinoma is a malignant tumor with low survival rate and high risk of metastasis and recurrence. Cisplatin-based chemotherapy is considered as the first-line treatment, but resistance to cisplatin limits its efficacy. This review outlines the mechanisms of cisplatin resistance and strategies to overcome it.

FRONTIERS IN ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies

Sepideh Mirzaei et al.

Summary: The failure of chemotherapy is a major challenge nowadays, and understanding the molecular pathways and mechanisms involved in chemoresistance is crucial for effective treatment of cancer patients. By regulating ROS and related molecular pathways, the sensitivity of cisplatin can be increased, leading to effective cancer treatment.

MOLECULES (2021)

Article Oncology

Histone deacetylase 1 facilitates aerobic glycolysis and growth of endometrial cancer

Qiongwei Wu et al.

Summary: The deregulation of HDAC1 plays a role in the progression of endometrial cancer by promoting aerobic glycolysis. High expression of HDAC1 is associated with advanced clinicopathological features and enhances cellular proliferation, invasion, migration, and tumorigenesis while inhibiting apoptosis. This study suggests HDAC1 as a potential target for endometrial cancer treatment.

ONCOLOGY LETTERS (2021)

Article Oncology

Histone Deacetylase (HDAC)-1,-2,-4, and-6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients' Survival

Georgia Levidou et al.

Summary: HDACs, especially HDAC-2, may play a significant role in the development and progression of uveal melanoma, with potential implications for patient prognosis. This study evaluated the expression of HDAC-1, -2, -4, and -6 in UM cases and found associations with tumor characteristics and patient survival.

CANCERS (2021)

Article Dentistry, Oral Surgery & Medicine

Ki67 Labelling Index predicts clinical outcome and survival in oral squamous cell carcinoma

Amol Ramchandra Gadbail et al.

Summary: The expression of Ki67 in oral squamous cell carcinoma is closely correlated with clinicopathological features and 3-5 year survival rates. High Ki67 LI is associated with adverse clinicopathological parameters and shorter survival time, while low Ki67 LI is associated with higher survival rates.

JOURNAL OF APPLIED ORAL SCIENCE (2021)

Review Oncology

Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer

Bartosz Mateusz Gasiorkiewicz et al.

Summary: Cisplatin resistance in cancer treatment is a common issue due to drug resistance, and autophagy modulation has become a key area of interest in overcoming this resistance. The role of autophagy in promoting or limiting carcinogenesis depending on the context encourages the search for substances modulating the process to alleviate cisplatin resistance. Such a strategy involves not only simple autophagy inhibition but also the harnessing of the process to induce autophagy-dependent cell death.

INVESTIGATIONAL NEW DRUGS (2021)

Review Cell Biology

Cancer stem cells: A review from origin to therapeutic implications

Mohammad Reza Atashzar et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Review Biochemistry & Molecular Biology

Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents

Loredana Cappellacci et al.

CURRENT MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Cell adhesion in cancer: Beyond the migration of single cells

Michalina Janiszewska et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Review Oncology

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance

Yena Cho et al.

FRONTIERS IN ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells

Chien-Hui Weng et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Oncology

Evolving insights: how DNA repair pathways impact cancer evolution

Jiadong Zhou et al.

CANCER BIOLOGY & MEDICINE (2020)

Article Biochemistry & Molecular Biology

Epigenetic alterations in cancer

Suganya Ilango et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2020)

Article Multidisciplinary Sciences

Enhancing cancer cell adhesion with clay nanoparticles for countering metastasis

Sahel N. Abduljauwad et al.

SCIENTIFIC REPORTS (2019)

Review Cell & Tissue Engineering

Cancer Stem Cells: Powerful Targets to Improve Current Anticancer Therapeutics

Rayana L. Bighetti-Trevisan et al.

STEM CELLS INTERNATIONAL (2019)

Review Oncology

Pancreatic cancer stem cells: features and detection methods

Toshiyuki Ishiwata et al.

PATHOLOGY & ONCOLOGY RESEARCH (2018)

Review Genetics & Heredity

Cancer epigenetics: Moving forward

Angela Nebbioso et al.

PLOS GENETICS (2018)

Review Oncology

Ki67 targeted strategies for cancer therapy

C. Yang et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2018)

Review Biotechnology & Applied Microbiology

Molecular mechanisms of drug resistance and its reversal in cancer

Melis Kartal-Yandim et al.

CRITICAL REVIEWS IN BIOTECHNOLOGY (2016)

Editorial Material Cell Biology

H2AX and EMT: deciphering beyond DNA repair

Urbain Weyemi et al.

CELL CYCLE (2016)

Review Oncology

Cancer drug resistance: redox resetting renders a way

Yuan Liu et al.

ONCOTARGET (2016)

Article Mathematical & Computational Biology

The Effect of Intrinsic and Acquired Resistances on Chemotherapy Effectiveness

Silvia A. Menchon

ACTA BIOTHEORETICA (2015)

Article Biotechnology & Applied Microbiology

Cellular Levels of Oxidative Stress Affect the Response of Cervical Cancer Cells to Chemotherapeutic Agents

Maria Filippova et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Review Biochemistry & Molecular Biology

Molecular mechanisms of cisplatin resistance

L. Galluzzi et al.

ONCOGENE (2012)

Review Oncology

Epigenetic regulation of cellular adhesion in cancer

Judith Katto et al.

CARCINOGENESIS (2011)

Article Biochemistry & Molecular Biology

Suberoylanilide Hydroxamic Acid (SAHA) at Subtoxic Concentrations Increases the Adhesivity of Human Leukemic Cells to Fibronectin

Katerina Kuzelova et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2010)

Review Biochemistry & Molecular Biology

Resistance mechanisms to cancer chemotherapy

Kelly Marie Redmond et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2008)